JAC Advance Access published online on September 20, 2005
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dki344
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Clinical Microbiology and Infectious Disease, Baskent University Faculty of Medicine, Ankara, Turkey
* To whom correspondence should be addressed. Objectives: To determine the risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection (UTI). Methods: The study was performed with isolates from community-acquired UTIs collected from 15 centres representing six different geographic regions of Turkey. All microbiological procedures were carried out in a central laboratory. Multivariate analysis was performed for detection of risk factors for resistance. Use of quinolones more than once within the last year, living in a rural area, having a urinary catheter, age >50 and complicated infections were included in the model as variables and logistic regression was performed. Results: A total of 611 Gram-negative isolates were studied: 321 were isolated from uncomplicated UTI and 290 were isolated from complicated UTI. E. coli was the causative agent in 90% of the uncomplicated UTIs and in 78% of the complicated UTIs (P < 0.001). Seventeen percent of E. coli strains isolated from uncomplicated cases and 38% of E. coli strains isolated from complicated UTI were found to be resistant to ciprofloxacin. In multivariate analysis, age over 50 [odds ratio (OR): 1.6; confidence interval (CI): 1.08-2.47; P = 0.020], ciprofloxacin use more than once in the last year (OR: 2.8; CI: 1.38-5.47; P = 0.004) and the presence of complicated UTI (OR: 2.4; CI: 1.54-3.61; P < 0.001) were found to be associated with ciprofloxacin resistance. Detection of strains of E. coli producing extended-spectrum Conclusions: The increasing prevalence of infections caused by antibiotic-resistant bacteria makes the empirical treatment of UTIs more difficult. One of the important factors contributing to these high resistance rates might be high antibiotic use. Urine culture and antimicrobial susceptibility testing are essential in Turkey for patients with UTI who have risk factors for resistance, such as previous ciprofloxacin use. Fluoroquinolone-sparing agents such as nitrofurantoin and fosfomycin should be evaluated as alternative therapies by further clinical efficacy and safety studies.
Received April 21, 2005
Revised August 1, 2005
Accepted August 30, 2005
Original article
Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey
2 Infectious Disease Clinics, Ankara Numune Education and Research Hospital, Ankara, Turkey
Özlem Kurt Azap, E-mail: okurtazap{at}baskent-ank.edu.tr
Abstract 
-lactamase (ESBL) enzymes was two times more common in the patients who received ciprofloxacin than those who did not (15% versus 7.4%).Participants are listed in the Acknowledgements section.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  K. G. Naber, L. Llorens, K. Kaniga, P. Kotey, D. Hedrich, and R. Redman Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3782 - 3792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yagci, F. Yoruk, A. Azap, and O. Memikoglu Prevalence and Risk Factors for Selection of Quinolone-Resistant Escherichia coli Strains in Fecal Flora of Patients Receiving Quinolone Therapy Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1287 - 1289. [Abstract] [Full Text] [PDF]
|
|